Skip to the content
ClearNote Health logologo darklogo light
  • Our Story
    • About Us
    • Leadership Team
    • FAQs
    • Careers
  • Our Approach
    • Epigenomics Platform
    • Clinical Trials
    • Publications
  • Our Products
    • Biopharma
    • Pancreatic Cancer
    • Ovarian Cancer
  • Our News
  • Contact Us
  • Order Test
Search
ClearNote Health logo
  • Our Story
    • About Us
    • Leadership Team
    • FAQs
    • Careers
  • Our Approach
    • Epigenomics Platform
    • Clinical Trials
    • Publications
  • Our Products
    • Biopharma
    • Pancreatic Cancer
    • Ovarian Cancer
  • Our News
  • Contact Us
  • Order Test
ClearNote Health logo
  • Our Story
    • About Us
    • Leadership Team
    • FAQs
    • Careers
  • Our Approach
    • Epigenomics Platform
    • Clinical Trials
    • Publications
  • Our Products
    • Biopharma
    • Pancreatic Cancer
    • Ovarian Cancer
  • Our News
  • Contact Us
  • Order Test
HomeDetection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA

Detection of early stage pancreatic cancer using 5-hydroxymethylcytosine signatures in circulating cell free DNA

ClearNote Health
February 2, 2026
Share share
  • .ln-icon{fill:#fff;}

Company

  • About Us
  • Leadership Team
  • Careers
  • Get In Touch

Information

  • Billing Rights & Protections
  • Cookie Policy
  • Privacy Policy
  • Terms of Use

©2026 ClearNote Health, All Rights Reserved.
Avantect and Virtuoso are trademarks of ClearNote Health. Other trademarks are the property of their respective owners.

Important Information
The Virtuoso platform is for research use only. Not for use in diagnostic procedures. The Avantect Pancreatic and Ovarian Cancers Tests are early detection tests. The tests do not establish a diagnosis of pancreatic cancer or ovarian cancer, respectively, and results should be considered in the context of other clinical criteria. Cancer statistics quoted on this website are taken from the CDC and SEER websites, 2025 data.

Back to top Drag
w